These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 10570018)
1. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018 [TBL] [Abstract][Full Text] [Related]
2. In vitro identification of the human cytochrome P-450 enzymes involved in the N-demethylation of azelastine. Imai T; Taketani M; Suzu T; Kusube K; Otagiri M Drug Metab Dispos; 1999 Aug; 27(8):942-6. PubMed ID: 10421623 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities. Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes. Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922 [TBL] [Abstract][Full Text] [Related]
5. Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes. Rochat B; Amey M; Gillet M; Meyer UA; Baumann P Pharmacogenetics; 1997 Feb; 7(1):1-10. PubMed ID: 9110356 [TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man. Venkatakrishnan K; von Moltke LL; Duan SX; Fleishaker JC; Shader RI; Greenblatt DJ J Pharm Pharmacol; 1998 Mar; 50(3):265-74. PubMed ID: 9600717 [TBL] [Abstract][Full Text] [Related]
7. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine. Wang RW; Liu L; Cheng H Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577 [TBL] [Abstract][Full Text] [Related]
8. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs. Venkatakrishnan K; von Moltke LL; Greenblatt DJ J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960 [TBL] [Abstract][Full Text] [Related]
9. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449 [TBL] [Abstract][Full Text] [Related]
10. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Hesse LM; Venkatakrishnan K; von Moltke LL; Shader RI; Greenblatt DJ Drug Metab Dispos; 2001 Feb; 29(2):133-40. PubMed ID: 11159802 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine. Tugnait M; Hawes EM; McKay G; Eichelbaum M; Midha KK Chem Biol Interact; 1999 Apr; 118(2):171-89. PubMed ID: 10359460 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1. Schmider J; Greenblatt DJ; Fogelman SM; von Moltke LL; Shader RI Biopharm Drug Dispos; 1997 Apr; 18(3):227-40. PubMed ID: 9113345 [TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546 [TBL] [Abstract][Full Text] [Related]
14. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096 [TBL] [Abstract][Full Text] [Related]
15. Nefiracetam metabolism by human liver microsomes: role of cytochrome P450 3A4 and cytochrome P450 1A2 in 5-hydroxynefiracetam formation. Fujimaki Y; Arai N; Nakazawa T; Fujimaki M J Pharm Pharmacol; 2001 Jun; 53(6):795-804. PubMed ID: 11428655 [TBL] [Abstract][Full Text] [Related]
16. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes. Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611 [TBL] [Abstract][Full Text] [Related]
17. Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Jang GR; Wrighton SA; Benet LZ Biochem Pharmacol; 1996 Sep; 52(5):753-61. PubMed ID: 8765473 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation. Oda Y; Kharasch ED J Pharmacol Exp Ther; 2001 Sep; 298(3):1021-32. PubMed ID: 11504799 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390 [TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]